Impact of Delivery Method Elite Athletes. (IDEA)

March 16, 2025 updated by: Jan Zapletal, Faculty Hospital Kralovske Vinohrady

The Impact of Delivery Method on the Performance of Elite Athletes.

Labor itself can occur spontaneously vaginally, with the help of extraction methods, or via cesarean section. It can also be planned or awaited for the spontaneous onset of uterine contractions. Each method has its advantages and disadvantages regarding potential damage to the pelvic floor and its stability in vaginal delivery or extraction methods, or concerning the stability of the abdominal wall with subsequent wound healing after a cesarean section.

The aim of the study is to retrospectively and prospectively determine the impact of the method of delivery on the performance of female athletes through a questionnaire study. Investigators would like to answer the question of whether cesarean delivery means a later return to training for athletes, whether pregnancy is problematic for female athletes in relation to their BMI, and whether pregnancy often signifies the end of a sports career for female athletes. The questionnaire also includes questions regarding overall women's health-menstrual cycle, incontinence, and mental health of female athletes. Prospectively, the questionnaire will be sent to all female athletes who meet representation limits once a year and for two years after retiring from the national team.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Childbirth and pregnancy are among the most significant moments in a woman's life. The method of delivery is currently a highly debated topic with potential impacts on a woman's future physical and mental health. For elite female athletes, this issue is amplified, as pregnancy and childbirth significantly affect their performance and careers, and it is often necessary to plan pregnancies in consideration of current sporting events and ongoing physical training.

Labor itself can occur spontaneously vaginally, with the help of extraction methods, or via cesarean section. It can also be planned or awaited for the spontaneous onset of uterine contractions. Each method has its advantages and disadvantages regarding potential damage to the pelvic floor and its stability in vaginal delivery or extraction methods, or concerning the stability of the abdominal wall with subsequent wound healing after a cesarean section.

The aim of the study is to retrospectively and prospectively determine the impact of the method of delivery on the performance of female athletes through a questionnaire study. The investigators would like to answer the question of whether cesarean delivery means a later return to training for athletes, whether pregnancy is problematic for female athletes in relation to their BMI, and whether pregnancy often signifies the end of a sports career for female athletes. The questionnaire also includes questions regarding overall women's health-menstrual cycle, incontinence, and mental health of female athletes. Prospectively, the questionnaire will be sent to all female athletes who meet representation limits once a year and for two years after retiring from the national team.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Czechia
      • Praha, Czechia, 11000
        • Recruiting
        • Faculty Hospital Královské Vinohrady
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

General young population for compering with the group of elite athletes which are meeting representation limits and included in national teams organized under the Czech Olympic Committee and individual sports federations.

Description

Inclusion Criteria:

- Elite female athletes meeting representation limits and included in national teams organized under the Czech Olympic Committee and individual sports federations.

Exclusion Criteria:

- Any male

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Retires elite athletes
Elite athletes with finished sport career
Elite athletes currently performing sport
Current elite athletes who are still doing sports and who will be asked about their career changes prospectively every year
General population
General population for comparing with previous groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance
Time Frame: 2 years retrospectively and through study completion, an average of 5 years
Best score will be used to compare performance of the athletes prior to delivery and after delivery
2 years retrospectively and through study completion, an average of 5 years
Performance
Time Frame: 2 years retrospectively and through study completion, an average of 5 years
Best time will be used to compare performance of the athletes prior to delivery and after delivery
2 years retrospectively and through study completion, an average of 5 years
Performance
Time Frame: 2 years retrospectively and through study completion, an average of 5 years
Most points scored will be used to compare performance of the athletes prior to delivery and after delivery
2 years retrospectively and through study completion, an average of 5 years
Placement of athletes during competitions
Time Frame: Prior to delivery and 2 years after the delivery
Best achievements according to athletes (for example 3rd place on Olympic Games) prior to delivery and after delivery
Prior to delivery and 2 years after the delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Faculty Hospital Kralovske Vinohrady

Investigators

  • Study Chair: Antonin Parizek, Prof., MUDr., General Faculty Hospital in Prague

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 16, 2025

Primary Completion (Estimated)

January 1, 2040

Study Completion (Estimated)

January 1, 2040

Study Registration Dates

First Submitted

January 20, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 16, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EK-VP/53/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study protocol, Ethical approval, Informed consent

IPD Sharing Time Frame

1.6.2025-1.1.2030

IPD Sharing Access Criteria

nternational Committee of Medical Journal Editors (ICMJE) and Ethical committee

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Section

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe